Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors

NCT02257476 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms
Malignancies

Interventions

DRUG: Carfilzomib
DRUG: Dexamethasone

Sponsor

Emory University

Collaborators

[object Object]